Digital holographic imaging is a label-free, non-toxic quantitative method that can be used for single cell analysis for a long time period. Sofia Kamlund, PhD, Lund University and Phase Holographic Imaging, has used this method in her thesis Not all those who wander are lost – A Study of Cancer Cells by Digital Holographic Imaging, Fluorescence and a combination there of. The technique allows the researcher to follow changes over time and evaluate cell response on living cells.
After two days of product training and education, knowledge sharing, positive discussions and success stories, we are happy to conclude that PHI´s first distributor meeting was a success. The meeting was held in Dubai November 26-27, on the topic A Change of Measure, and included everything from the introduction of new HoloMonitor development to inspiring
Globally, prostate cancer is the second most commonly occurring cancer in men and the fourth most commonly occurring cancer overall. This video shows Etoposide treated DU 145 prostate cancer cells undergoing programed cell death, apoptosis.
Sofia Kamlund has studied Cell Division and Cell Movement using Digital Holographic Microscopy. Her research presents new ways of analyzing individual cells by using Holographic Microscopy alone or in combination with Fluorescence Microscopy.
PHI had a successful Holomonitor User Meeting where we discussed how to use HoloMonitor with focus on cancer research. The presentations showed new methods within cancer research and cell biology.
PHI’s Industrial Doctoral Student Louise Stenbaeck received a price from Danish Cancer Society for her poster “Holographic microscopy: Macrophage-uptake of SA-MIPs”. Louise’s poster showed something new within cancer research on cell level. Her research within cell proliferation shows that morphological parameters and treatment with the plastic nanoparticles MIP:s (molecularly imprinted polymers) increased the values for cell